Abstract:Background: Hepatitis B virus (HBV) infection has remained a significant public health problem. Generating a large-scale, community-based profile of HBV infection in China is essential to prevention of the disease. Objectives: The current study was designed to investigate HBV-infected individuals at the community level and determine the age distribution, hepatitis B e antigen (HBeAg) positivity and its related risk factors, relationship among serological markers. Patients and Methods: A cross-sectional, community-based survey was carried out without age restriction, in 12 communities of two counties. The study population was selected by random multistage cluster sampling. Serological samples and demographic information were collected from 8439 HB surface antigen (HBsAg)-positive individuals. Results: The constituent ratio of individuals with HBsAg-positive infections was lowest among persons aged < 20 years (0.4%) and the highest among persons aged 40-49 years (33.2%). The HBeAg-positive rate among infected individuals was 18.5%, and the constituent ratio decreased with increasing of age. The HBeAg-positive rate in males (21.9%) was significantly higher than in females (14.7%), and was higher among coastland inhabitants (22.9%) than among plains inhabitants (12.9%). Among the 1561 HBeAg-positive individuals, 91.0% were HBV DNA-positive. However, of the 6878 HBeAg-negative individuals, only 45.4% were HBV DNA-positive, and the HBeAg-positive rate was significantly different at different levels of HBV DNA expression. The proportion of detectable HBV DNA levels was significantly higher in individuals with elevated ALT, compared to those with normal ALT, regardless of HBeAg-positivity. Conclusions: The HBV prevalence remained high in the > 20 age group. The positivity of HBeAg was related to age, region, and sex. Testing HBeAg and serum ALT levels were effective ways to assess HBV infectiousness in community-level hospitals in China.

Reply Letter Regarding Seroconversion of Hepatitis B Surface Antigen in a Successful Long-Term Immune Cohort

HBcrAg, Pg RNA and HBsAg Dynamically Supervise the Seroconversion of HBsAg with Anti-Viral Therapy "loss of HBsAg" Maybe Not a Good End-Point of Anti-Viral Therapy

Seroconversion Through IL-21 in Patients with Chronic HBV Infection

Requirement for Further Validation on the Seroconversion of Hepatitis B Surface Antigen in Successful Vaccinees.

Longitudinal Mapping of Hepatitis B Vaccine-Induced B-cell Linear Epitopes in Healthy Individuals

Circulating Chemokine (C-X-C Motif) Receptor 5+CD4+T Cells Benefit Hepatitis B E Antigen Seroconversion Through IL-21 in Patients with Chronic Hepatitis B Virus Infection

HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients

Sustained Serological and Complete Responses in HBeAg-positive Patients Treated with Peginterferon Alfa-2B: a 6-Year Long-Term Follow-Up of a Multicenter, Randomized, Controlled Trial in China

The impact of hepatitis B surface antigen seroconversion on the durability of functional cure induced by pegylated interferon alpha treatment

Serolological Profile among HBsAg-Positive Infections in Southeast China: A Community-Based Study

Response to Chen and Liaw

Favorable Outcome of Extended Treatment with Adding Pegylated Interferonα-2a to Entecavir for HBeAg-positive Chronic Hepatitis B: a Case Report.

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.

Natural History of Hepatitis B E Antigen to Antibody Seroconversion in Patients with Normal Serum Aminotransferase Levels

[Epidemiological Characteristics of HBeAg Reversion in Chronic Hepatitis B Patients with HBeAg Seroconversion in Jiangsu Province, 2012-2014].

Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis

Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment

Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China

Responses to Hepatitis B Vaccine in Isolated Anti-Hbc Positive Adults.

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection

Serum Hbeag Sero-Conversion Correlated with Decrease of Hbsag and Hbv Dna in Chronic Hepatitis B Patients Treated with A Therapeutic Vaccine